Genetics of influenza viruses

Annual Review of Genetics

Volumn 36, Issue , 2002, Pages 305-332

  Steinhauer, David A ^a   Skehel, John J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Antigenicity; Mutants; Pathogenicity; Reassortment; Recombination

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; EPIDEMIC; GENETIC RECOMBINATION; HUMAN; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; VIRAL GENETICS; VIROLOGY; VIRUS STRAIN;

ANTIGENS, VIRAL; GENOME, VIRAL; ORTHOMYXOVIRIDAE; RECOMBINATION, GENETIC; RNA, VIRAL;

INFLUENZA A VIRUS; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0036953373     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.36.052402.152757     Document Type: Review

References (176)

1. Air GM, Els MC, Brown LE, Laver WG, Webster RG. 1985. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Virology 145:237-48
2. Akkina RK, Chambers TM, Nayak DP. 1984. Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells. J. Virol. 51:395-403
3. Baere AS, Webster RG. 1991. Replication of avian influenza viruses in humans. Arch. Virol. 119:37-42
4. Baigent SJ, McCauley JW. 2001. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res. 79:177-85
5. Baron S, Jensen KE. 1955. Evidence for genetic interaction between non-infectious and infectious influenza A viruses. J. Exp. Med. 102:677-97
6. Barrett T, Wolstenholme AJ, Mahy BW. 1979. Transcription and replication of influenza virus RNA. Virology 98:211-25
7. Barry RD. 1961. The multiplication of influenza virus. II. Multiplicity reactivation of ultraviolet irradiated virus. Virology 14:398-405
8. Bean WJ Jr, Simpson RW. 1976. Transcriptase activity and genome composition of defective influenza virus. J. Virol. 18:365-69
9. Beaton AR, Krug RM. 1986. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5′ capped end. Proc. Natl. Acad. Sci. USA 83:6282-86
10. Bender C, Hall H, Huang J, Klimov A, Cox N, et al. 1999. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254:115-23
11. Bergmann M, Garcia-Sastre A, Palese P. 1992. Transfection-mediated recombination of influenza A virus. J. Virol. 66:7576-80
12. Bergmann M, Muster T. 1995. The relative amount of an influenza A virus segment present in the viral particle is not affected by a reduction in replication of that segment. J. Gen. Virol. 76:3211-15
13. Betakova T, Nermut MV, Hay AJ. 1996. The NB protein is an integral component of the membrane of influenza B virus. J. Gen. Virol. 77:2689-94
14. Biswas SK, Nayak DP. 1994. Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. J. Virol. 68:1819-26
15. Bizebard T, Barbey-Martin C, Fleury D, Gigant B, Barrere B, et al. 2001. Structural studies on viral escape from antibody neutralization. Curr. Top. Microbiol. Immunol. 260:55-64
16. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, et al. 1995. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 376:92-94
17. Brassard DL, Leser GP, Lamb RA. 1996. Influenza B virus NB glycoprotein is a component of the virion. Virology 220:350-60
18. Bukrinskaya AG, Vorkunova NK, Kornilayeva GV, Narmanbetova RA, Vorkunova GK. 1982. Influenza virus uncoating in infected cells and effect of rimantadine. J. Gen. Virol. 60:49-59
19. Burnet FM, Lind PE. 1949. Recombination of characters between two influenza virus strains. Aust. J. Sci. 12:109-10
20. Burnet FM, Lind PE. 1951. A genetic approach to variation in influenza viruses. 3. Recombination of characters in influenza virus strains used in mixed infections. J. Gen. Microbiol. 5:59-66
21. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-27
22. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409-17
23. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-12
24. Chizhmakov IV, Geraghty FM, Ogden DC, Hayhurst A, Antoniou M, Hay AJ. 1996. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J. Physiol. 494:329-36
25. Choppin PW, Murphy JS, Tamm I. 1960. Studies of two kinds of virus particles which comprise influenza A2 strains. III. Morphological characteristics: independence of morphological and functional traits. J. Exp. Med. 112:945-52
26. Chu CM, Dawson IM, Elford WJ. 1949. Filamentous forms associated with newly isolated influenza virus. Lancet i:602-3
27. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, et al. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-77
28. Colman PM, Varghese JN, Laver WG. 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41-44
29. Daniels RS, Downie JC, Hay AJ, Knossow M, Skehel JJ, et al. 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40:431-39
30. Davies WL, Grunert RR, Haff RF, McGahen JW, Neumayer EM, et al. 1964. Antiviral activity of 1-adamantanamine (amantadine). Science 144:862-63
31. Deshpande KL, Fried VA, Ando M, Webster RG. 1987. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. USA 84:36-40
32. Donald HB, Issacs A. 1954. Counts of influenza virus particles. J. Gen. Microbiol. 10:457-64
33. Duhaut SD, McCauley JW. 1996. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 216:326-37
34. Dybing JK, Schultz-Cherry S, Swayne DE, Suarez DL, Perdue ML. 2000. Distinct pathogenesis of Hong Kong-origin H5N1 viruses in mice compared to that of other highly pathogenic H5 avian influenza viruses. J. Virol. 74:1443-50
35. Enami M, Fukuda R, Ishihama A. 1985. Transcription and replication of eight RNA segments of influenza virus. Virology 142:68-77
36. Enami M, Luytjes W, Krystal M, Palese P. 1990. Introduction of site-specific mutations into the genome of influenza virus. Proc. Natl. Acad. Sci. USA 87:3802-5
37. Enami M, Sharma G, Benham C, Palese P. 1991. An influenza virus containing nine different RNA segments. Virology 185:291-98
38. Fields S, Winter G. 1981. Nucleotide-sequence heterogeneity and sequence rearrangements in influenza virus cDNA. Gene 15:207-14
39. Fields S, Winter G. 1982. Nucleotide sequences of influenza virus segments 1 and 3 reveal mosaic structure of a small viral RNA segment. Cell 28:303-13
40. Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6:530-34
41. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-82
42. Gao P, Watanabe S, Ito T, Goto H, Wells K, et al. 1999. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 73:3184-89
43. Garcia-Sastre A. 2001. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375-84
44. Garcia-Sastre A, Palese P. 1993. Genetic manipulation of negative-strand RNA virus genomes. Annu. Rev. Microbiol. 47:765-90
45. Garcia-Sastre A, Palese P. 1995. The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in packaging this protein into viral envelopes. Virus Res. 37:37-47
46. Gerhard W. 2001. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 260:171-90
47. Ghendon YZ, Markushin SG, Klimov AI, Hay AJ. 1982. Studies of fowl plague virus temperature-sensitive mutants with defects in transcription. J. Gen. Virol. 63:103-11
48. Gibbs MJ, Armstrong JS, Gibbs AJ. 2001. Recombination in the hemagglutinin gene of the 1918 "Spanish flu." Science 293:1842-45
49. Goto H, Kawaoka Y. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. USA 95:10224-28
50. Grambas S, Bennett MS, Hay AJ. 1992. Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses. Virology 191:541-49
51. Grambas S, Hay AJ. 1992. Maturation of influenza A virus hemagglutinin-estimates of the pH encountered during transport and its regulation by the M2 protein. Virology 190:11-18
52. Gubareva LV, Bethell R, Hart GJ, Murti KG, Penn CR, Webster RG. 1996. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70:1818-27
53. Gubareva LV, Kaiser L, Hayden FG. 2000. Influenza virus neuraminidase inhibitors. Lancet 355:827-35
54. Gubareva LV, McCullers JA, Bethell RC, Webster RG. 1998. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592-96
55. Hatta M, Gao P, Halfmann P, Kawaoka Y. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840-42
56. Hay A, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. 1986. Molecular basis of resistance of influenza A viruses to amantadine. J. Antimicrobiol. Chemother. 18(Suppl. B): 19-29
57. Hay AJ, Kennedy NC, Skehel JJ, Appleyard G. 1979. The matrix protein gene determines amantadine-sensitivity of influenza viruses. J. Gen. Virol. 42:189-91
58. Hay AJ, Skehel JJ, McCauley J. 1982. Characterization of influenza virus RNA complete transcripts. Virology 116:517-22
59. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-24
60. Henle W, Liu OC. 1951. Studies on host-virus interactions in the chick embryo influenza virus system. J. Exp. Med. 94:305-22
61. Hinshaw VS, Webster RG, Easterday BC, Bean WJ. 1981. Replication of avian influenza A viruses in mammals. Infect. Immunol. 34:354-61
62. Hinshaw VS, Webster RG, Naeve CW, Murphy BR. 1983. Altered tissue tropism of human-avian reassortant influenza viruses. Virology 128:260-63
63. Hirst GK. 1962. Genetic recombination with Newcastle disease virus, poliovirus, and influenza. Cold Spring Harbor Symp. Quant. Biol. 27:303-8
64. Hirst GK, Gotlieb T. 1955. The experimental production of combination forms of virus. V. Alterations in the virulence of neurotropic influenza virus as a result of mixed infection. Virology 1:221-35
65. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-13
66. Holsinger LJ, Lamb RA. 1991. Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183:32-43
67. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y. 1994. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 68:6074-78
68. Horisberger MA. 1982. Identification of a catalytic activity of the large basic P polypeptide of influenza virus. Virology 120:279-86
69. Horne RW, Waterson AP, Wildy P, Farnham AP. 1960. The structure and composition of myxoviruses. I. Electron microscope studies of the structure of myxovirus particles by negative staining techniques. Virology 11:79-98
70. Horvath CM, Williams MA, Lamb RA. 1990. Eukaryotic coupled translation of tandem cistrons: identification of the influenza B virus BM2 polypeptide. EMBO J. 9:2639-47
71. Hoyle L, Horne RW, Waterson AP. 1961. The structure and composition of the myxoviruses II. Components released from the influenza virus particle by ether. Virology 13:448-59
72. Hughes MT, McGregor M, Suzuki T, Suzuki Y, Kawaoka Y. 2001. Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J. Virol. 75:3766-70
73. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72:7367-73
74. Jennings PA, Finch JT, Winter G, Robertson JS. 1983. Does the higher order structure of the influenza virus ribonucleo-protein guide sequence rearrangements in influenza viral RNA? Cell 34:619-27
75. Kato N, Eggers HJ. 1969. Inhibition of uncoating of fowl plague virus by ladamantanamine hydrochloride. Virology 37:632-41
76. Katz JM, Lu X, Tumpey TM, Smith CB, Shaw MW, Subbarao K. 2000. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74:10807-10
77. Kawaoka Y, Krauss S, Webster RG. 1989. Avian-to-human transmission of of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. J. Virol. 63:4603-8
78. Kawaoka Y, Naeve CW, Webster RG. 1984. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 139:303-16
79. Kawaoka Y, Webster RG. 1989. Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin. J. Virol. 63:3296-300
80. Kendal AP NG, Skehel JJ, Dowdle WR. 1978. Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977-1978 to "Scandinavian" strains isolated in epidemics of 1950-1951. Virology 89:632-36
81. Khatchikian D, Orlich M, Rott R. 1989. Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature 340:156-57
82. Kida HIT, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, et al. 1994. Potential for transmission of avian influenza viruses to pigs. J. Gen. Virol. 75:2183-88
83. Klenk HD, Garten W. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:39-43
84. Klenk HD, Rott R, Orlich M, Blodorn J. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-39
85. Knipe DM, Howley PM, eds. 2001. Fields Virology. Philadelphia: Lippincott, Williams & Wilkins
86. Krug RM, Ueda M, Palese P. 1975. Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J. Virol. 16:790-96
87. Lamb RA, Choppin PW. 1983. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52:467-506
88. Lamb RA, Krug RM. 2001. Orthomyxoviridae: the viruses and their replication. See Ref. 84a, pp. 1487-531
89. Lazarowitz SG, Choppin PW. 1975. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68:440-54
90. Li ML, Rao P, Krug RM. 2001. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 20:2078-86
91. Li S, Schulman J, Itamura S, Palese P. 1993. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J. Virol. 67:6667-73
92. Lin YP, Shaw M, Gregory V, Cameron K, Lim W, et al. 2000. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. USA 97:9654-58
93. Lind PE, Burnet FM. 1957. Recombination between virulent and non-virulent strains of influenza virus. 2. The behavior of virulence markers on recombination. Aust. J. Exp. Biol. Med. Sci. 35:67-78
94. Liu C, Air GM. 1993. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194:403-7
95. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:5903-11
96. Lubeck MD, Schulman JL, Palese P. 1978. Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J. Virol. 28:710-16
97. Ludwig S, Vogel U, Scholtissek C. 1995. Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus. Arch. Virol. 140:945-50
98. Luytjes W, Krystal M, Enami M, Pavin JD, Palese P. 1989. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107-13
99. Maassab HF, Bryant ML. 1999. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9:237-44
100. Mahy BWJ. 1983. Mutants of influenza virus. In Genetics of Influenza Viruses, ed. DW Kingsbury, P Palese, pp. 192-254. Berlin: Springer-Verlag
101. Martin J, Wharton SA, Lin YP, Takemoto DK, Skehel JJ, et al. 1998. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241:101-11
102. Martin K, Helenius A. 1991. Nuclear transport of influenza virus ribonucleo-proteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-30
103. Mayer V, Schulman JL, Kilbourne ED. 1973. Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A/NWS (H0N1) influenza virus. J. Virol. 11:272-78
104. McGeoch D, Fellner P, Newton C. 1976. The influenza virus genome consists of eight distinct RNA species. Proc. Natl. Acad. Sci. USA 73:3045-49
105. McKimm-Breschkin JL. 2000. Resistance of influenza viruses to neuraminidase inhibitors-a review. Antiviral Res. 47:1-17
106. Mitnaul LJ, Castrucci MR, Murti KG, Kawaoka Y. 1996. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 70:873-79
107. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, et al. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74:6015-20
108. Morris SJ, Price GE, Barnett JM, Hiscox SA, Smith H, Sweet C. 1999. Role of neuraminidase in influenza virus-induced apoptosis. J. Gen. Virol. 80:137-46
109. Mowshowitz SL. 1978. P1 is required for initiation of cRNA synthesis in WSN influenza virus. Virology 91:493-95
110. Mukaigawa J, Hatada E, Fukuda R, Shimizu K. 1991. Involvement of the influenza A virus PB2 protein in the regulation of viral gene expression. J. Gen. Virol. 72:2661-70
111. Muster T, Subbarao EK, Enami M, Murphy BR, Palese P. 1991. An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice. Proc. Natl. Acad. Sci. USA 88:5177-81
112. Nakajima K, Desselberger U, Palese P. 1978. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274:334-39
113. Nakajima K, Ueda M, Sugiura A. 1979. Origin of small RNA in von Magnus particles of influenza virus. J. Virol. 29:1142-48
114. Nayak DP, Chambers TM, Akkina RK. 1985. Defective-interfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. Curr. Top. Microbiol. Immunol. 114:103-51
115. Neumann G, Kawaoka Y. 2001. Reverse genetics of influenza virus. Virology 287:243-50
116. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, et al. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-50
117. Neumann G, Zobel A, Hobom G. 1994. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 202:477-79
118. Nichol ST, Penn CR, Mahy BW. 1981. Evidence for the involvement of influenza A (fowl plague Rostock) virus protein P2 in ApG and mRNA primed in vitro RNA synthesis. J. Gen. Virol. 57:407-13
119. Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M. 2000. Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo- and adipotropic infection. J. Gen. Virol. 81:2503-10
120. Nuss JM, Whitaker PB, Air GM. 1993. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase. Proteins 15:121-32
121. Odagiri T, Tanaka T, Tobita K. 1987. Temperature-sensitive defect of influenza A/Ann Arbor/6/60 cold-adapted variant leads to a blockage of matrix polypeptide incorporation into the plasma membrane of the infected cells. Virus Res. 7:203-18
122. Orlich M, Gottwald H, Rott R. 1994. Non-homologous recombination between the hemagglutinin gene and the nucleoprorein gene of an influenza virus. Virology 204:462-65
123. Palese P, Ritchey MB, Schulman JL. 1977. P1 and P3 proteins of influenza virus are required for complementary RNA synthesis. J. Virol. 21:1187-95
124. Palese P, Schulman JL. 1976. Differences in RNA patterns of influenza A viruses. J. Virol. 17:876-84
125. Palese P, Tobita K, Ueda M, Compans RW. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410
126. Palese P, Young JF. 1982. Variation of influenza A, B, and C viruses. Science 215:1468-74
127. Pekosz A, Lamb RA. 2000. Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus. J. Virol. 74:10480-88
128. Pinto LH, Holsinger LJ, Lamb RA. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-28
129. Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. 1996. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:4188-92
130. Plotch SJ, Bouloy M, Krug RM. 1979. Transfer of 5′-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc. Natl. Acad. Sci. USA 76:1618-22
131. Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847-58
132. Poch O, Blumberg BM, Bougueleret L, Tordo N. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J. Gen. Virol. 71:1153-62
133. Pons MW. 1976. A re-examination of influenza single-and double-stranded RNAs by gel electrophoresis. Virology 69:789-92
134. Rey O, Nayak DP. 1992. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66:5815-24
135. Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC. 1983. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304:76-78
136. Rohde W, Scholtissek C. 1980. On the offgin of the gene coding for an influenza A virus nucleocapsid protein. Arch. Virol. 64:213-23
137. Rosenthal PB, Zhang X, Formanowski F, Fitz W, Wong CH, et al. 1998. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 396:92-96
138. Rott R, Orlich M, Scholtissek C. 1979. Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains. J. Gen. Virol. 44:471-77
139. Schlesinger RW, Husak PJ, Bradshaw GL, Panayotov PP. 1998. Mechanisms involved in natural and experimental neuropathology of influenza viruses: evidence and speculation. Adv. Virus Res. 50:289-379
140. Scholtissek C, Bowles AL. 1975. Isolation and characterization of temperature-sensitive mutants of fow1 plague virus. Virology 67:576-87
141. Scholtissek C, Burger H, Kistner O, Shortridge KF. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287-94
142. Scholtissek C, Rohde W, Harms E, Rott R, Orlich M, Boschek CB. 1978. A possible partial heterozygote of an influenza A virus. Virology 89:506-16
143. Scholtissek C, Rott R, Orlich M, Harms E, Rohde W. 1977. Correlation of pathogenicity and gene constellation of an influenza A virus (fowl plague). I. Exchange of a single gene. Virology 81:74-80
144. Scholtissek C, von Hoyningen V, Rott R. 1978. Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology 89:613-17
145. Scholtissek C, von Hoyningen V, Rott R. 1978. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87:13-20
146. Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, Kawaoka Y, Hinshaw VS. 2001. Influenza virus ns1 protein induces apoptosis in cultured cells. J. Virol. 75:7875-81
147. Schultz-Cherry S, Hinshaw VS. 1996. Influenza virus neuraminidase activates latent transforming growth factor beta. J. Virol. 70:8624-29
148. Shapiro GI, Krug RM. 1988. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J. Virol. 62:2285-90
149. Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, et al. 1998. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-42
150. Simpson RW, Hirst GK. 1968. Temperature-sensitive mutants of influenza A virus: isolation of mutants and preliminary observations on genetic recombination and complementation. Virology 35:41-49
151. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-69
152. Smith FL, Palese P. 1989. Variation in influenza virus genes: epidemiology, pathogenic, and evolutionary consequenses. In The Influenza Viruses, ed. RM Krug, pp. 319-59. New York: Plenum
153. Smith GL, Hay AJ. 1982. Replication of the influenza virus genome. Virology 118:96-108
154. Steinhauer DA. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20
155. Steinhauer DA, Wharton SA, Skehel JJ, Wiley DC, Hay AJ. 1991. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc. Natl. Acad. Sci. USA 88:11525-29
156. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, et al. 1992. Influenza virus hemagglutinin with multi-basic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11:2407-14
157. Suarez DL, Perdue ML, Cox N, Rowe T, Bender C, et al. 1998. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72:6678-88
158. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-96
159. Sugiura A, Ueda M, Tobita K, Enomoto C. 1975. Further isolation and characterization of temperature-sensitive mutants of influenza virus, Virology 65:363-73
160. Sugrue RJ, Bahadur G, Zambon MC, Hall-Smith M, Douglas AR, Hay AJ. 1990. Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 9:3469-76
161. Sugrue RJ, Hay AJ. 1991. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180:617-24
162. Ulmanen I, Broni BA, Krug RM. 1981. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. USA 78:7355-59
163. von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, et al. 1993. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418-23
164. Wang ML, Skehel JJ, Wiley DC. 1986. Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J. Virol. 57:124-28
165. Webster RG, Air GM, Metzger DW, Colman PM, Varghese JN, et al. 1987. Antigenic structure and variation in an influenza virus N9 neuraminidase. J. Virol. 61:2910-16
166. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-79
167. Webster RG, Rott R. 1987. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 50:665-66
168. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-94
169. Worobey M, Rambaut A, Pybus OG, Robertson DL. 2002. Questioning the evidence for genetic recombination in the 1918 "Spanish flu" virus. Science 296:211
170. Wright PF, Webster RG. 2001. Orthomyxoviruses. See Ref. 84a, pp. 1533-79
171. Wrigley NG, Brown EB, Daniels RS, Douglas AR, Skehel JJ, Wiley DC. 1983. Electron microscopy of influenza haemagglutinin-monoclonal antibody complexes. Virology 131:308-14
172. Yamashita M, Krystal M, Palese P. 1988. Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA. J. Virol. 62:3348-55
173. Yang P, Bansal A, Liu C, Air GM. 1997. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 229:155-65
174. Young JF, Palese P. 1979. Evolution of human influenza A viruses in nature: recombination contributes to genetic variation of H1N1 strains. Proc. Natl. Acad. Sci. USA 76:6547-51
175. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-71
176. Zhirnov OP. 1990. Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses. Virology 176:274-79